Novo Nordisk's market cap is currently kr203.25B. The company's EPS TTM is €0.7979248; its P/E ratio is 13.73; and it has a dividend yield of 3.35%. Novo Nordisk is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is €0.67. See an overview of income statement, balance sheet, and cash flow financials.
